February 2020, Volume :50 Number 2 , page 31 - 38 [Buy]
Join NursingCenter to get uninterrupted access to this Article
istradefylline, omadacycline tosylate, pitolisant hydrochloride, prucalopride succinate, romosozumab-aqqg, sarecycline hydrochloride, solriamfetol hydrochloride
Abstract: This article reviews seven drugs recently approved by the FDA, including indications, precautions, adverse reactions, and nursing considerations.
Join NursingCenter on Social Media to find out the latest news and special offers
© 2024 Wolters Kluwer Health, Inc. and/or its subsidiaries. All rights reserved. – Terms & Conditions – Privacy Policy – Disclaimer – Your California Privacy Choices -- v09.08.00